Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
13.21
-0.09 (-0.68%)
Dec 20, 2024, 4:00 PM EST - Market closed

Pliant Therapeutics Revenue

In the year 2023, Pliant Therapeutics had annual revenue of $1.58M, down -83.69%.

Revenue (ttm)
$1.58M
Revenue Growth
-83.69%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
158
Market Cap
803.88M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.58M-8.11M-83.69%
Dec 31, 20229.69M2.11M27.91%
Dec 31, 20217.57M-34.25M-81.89%
Dec 31, 202041.82M-15.24M-26.70%
Dec 31, 201957.05M--
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
agilon health 5.59B
Healthcare Services Group 1.70B
Ironwood Pharmaceuticals 378.42M
Paragon 28 245.00M
Cytek Biosciences 201.21M
Avid Bioservices 150.45M
AbCellera Biologics 32.96M
uniQure 28.59M
Revenue Rankings